JPRN-jRCTc050190121
Recruiting
Phase 1
Intrauterine administration of autologous peripheral blood mononuclear cells in patients with repeated implantation failure. - IUAPT
Mandai Masaki0 sites200 target enrollmentMarch 19, 2020
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- infertile woman
- Sponsor
- Mandai Masaki
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •the patients with repeated(over three times) implantation failure
Exclusion Criteria
- •Women whose age are under 17 or ovre 47 years old. Infertile women who cannot get high\-grade blastcysts in In vitro fertilization (IVF) treatment cycles.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Intrauterine administration of autologous peripheral blood mononuclear cells in patients with repeated implantation failure.patients with repeated implantation failureJPRN-UMIN000022434Kyoto University100
Recruiting
Phase 3
Autologous platelet-rich plasma in women with Asherman's syndromeAsherman Syndrome.Intrauterine synechiaeIRCT20110509006420N17Yazd University of Medical Sciences30
Recruiting
Phase 2
For Increase in Endometrial Thickness in Women With Thin Endometrium undergoing Infertility Treatment use of Intrauterine Infusion Of Autologous Platelet Rich Plasma (PRP) and Granulocyte Colony Stimulating Factor (G-CSF)Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperiumCTRI/2024/03/064601Datta megha institute of higher education and research
Completed
Not Applicable
Role of autologous Platelet rich plasma in infertile females.Health Condition 1: - Health Condition 2: N979- Female infertility, unspecifiedCTRI/2021/05/033764vmmc and safdarjung hospital delhi
Completed
Not Applicable
Role of platelet rich plasma in infertile females with thin endometriumCTRI/2022/05/042399not applicable